BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12004326)

  • 1. Anti-p200 pemphigoid: diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease.
    Egan CA; Yee C; Zillikens D; Yancey KB
    J Am Acad Dermatol; 2002 May; 46(5):786-9. PubMed ID: 12004326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Korean case of anti-p200 pemphigoid.
    Cho SB; Kim SC
    Yonsei Med J; 2003 Oct; 44(5):931-4. PubMed ID: 14584115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
    Raffin D; Delaplace M; Roussel A; Estève E
    Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-p200 pemphigoid: a spectacular response to dapsone].
    Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
    Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
    Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
    JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.
    Dilling A; Rose C; Hashimoto T; Zillikens D; Shimanovich I
    J Dermatol; 2007 Jan; 34(1):1-8. PubMed ID: 17204094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of subepidermal blistering disease with anti-p200 or 180-kD bullous pemphigoid antigen associated with psoriasis.
    Yasuda H; Tomita Y; Shibaki A; Hashimoto T
    Dermatology; 2004; 209(2):149-55. PubMed ID: 15316172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
    Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin-induced anti-p200 pemphigoid: an unusual morphology.
    Wozniak K; Kowalewski C; Hashimoto T; Ishii N; Glinska-Wielochowska M; Schwartz RA
    Acta Derm Venereol; 2006; 86(5):443-6. PubMed ID: 16955192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of anti-p200 pemphigoid with autoantibodies against both a novel 200-kD dermal antigen and the 290-kD epidermolysis bullosa acquisita antigen.
    Furukawa H; Miura T; Takahashi M; Nakamura K; Kaneko F; Ishii F; Komai R; Hashimoto T
    Dermatology; 2004; 209(2):145-8. PubMed ID: 15316171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA anti-p200 pemphigoid.
    Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
    Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathology of anti-p200 pemphigoid.
    Rose C; Weyers W; Denisjuk N; Hillen U; Zillikens D; Shimanovich I
    Am J Dermatopathol; 2007 Apr; 29(2):119-24. PubMed ID: 17414431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
    Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
    Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-p200 pemphigoid--a new bullous autoimmune dermatosis].
    Shimanovich I; Rose C; Hirako Y; Butt-Dörje E; Zillikens D
    J Dtsch Dermatol Ges; 2004 Jan; 2(1):7-14. PubMed ID: 16281877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-p200 pemphigoid.
    Goletz S; Hashimoto T; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic bullous disease of childhood with IgG reactivity to p200 antigen.
    Patsatsi A; Meltzanidou P; Katafigiotis S; Sotiriadis D; Schmidt E; Lambropoulos A
    Int J Dermatol; 2017 Jul; 56(7):773-775. PubMed ID: 28436028
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
    García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
    Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of unique subepidermal blistering disease with autoantibodies against a novel dermal 200-kD antigen.
    Kawahara Y; Matsuo Y; Hashimoto T; Nishikawa T
    Dermatology; 1998; 196(2):213-6. PubMed ID: 9568410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-p200 pemphigoid].
    Holtsche MM; Goletz S; Zillikens D
    Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.